BiotechTube
Regen Lab

Regen Lab

Mont-sur-Lausanne, Switzerland· Est.
regenlab.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Regen Lab SA is a privately held, commercial-stage leader in the regenerative medicine device sector, with a 20-year history of innovation. The company's core business revolves around proprietary, CE-marked medical devices that enable healthcare professionals to prepare autologous biologics like PRP, PRP-HA combinations, and cellular matrices at the point of care. It has established a strong global presence through its focus on quality, regulatory compliance, and a diversified portfolio addressing the high-growth aesthetics and orthopaedic markets. Regen Lab operates on a business-to-business (B2B) model, selling its kits and devices to clinics and hospitals worldwide.

AestheticsOrthopaedicsWound Care

Technology Platform

Proprietary medical devices for the point-of-care preparation of autologous biologics, including platelet-rich plasma (PRP), PRP-hyaluronic acid (HA) combinations, autologous thrombin serum (ATS), and extracellular matrix products.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

Significant growth is driven by the global trend towards minimally invasive, autologous treatments in aesthetics and orthopaedics.
The upcoming launch of a standalone Hyaluronic Acid product line allows the company to enter the large and lucrative dermal filler market directly.
Geographic expansion into new regions presents a clear avenue for increasing revenue.

Risk Factors

The company faces intense competition in the crowded PRP and aesthetic device markets and must defend its IP.
Regulatory hurdles, including maintaining CE marks under the EU's MDR, pose a constant operational risk.
Variability in clinical evidence and inconsistent insurance reimbursement for procedures could limit broader adoption.

Competitive Landscape

Regen Lab competes in a fragmented market with numerous other medical device companies offering PRP preparation systems, such as EmCyte, Arthrex, and Zimmer Biomet. In the aesthetics space, competition extends to major dermal filler companies like Allergan (AbbVie) and Galderma. Its differentiation relies on product innovation (e.g., PRP-HA combinations), quality, and a comprehensive portfolio for the regenerative medicine practitioner.

More companies in Switzerland →